[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635106":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":30,"centralContacts":34,"locations":40,"responsibleParty":55,"collaborators":57,"id":60,"slug":25,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":25,"eligibilityCriteria":65,"healthyVolunteers":61,"sex":66,"minAge":67,"maxAge":25,"enrollmentInfo":68,"targetDuration":25,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":43,"whyStopped":25,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Montefiore Medical Center","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Implementation Phase","EXPERIMENTAL","Clinics will sequentially transition from the usual care (control) condition to the intervention phase at three-month intervals until all clusters receive the intervention.\n\nThe active implementation phase at each cluster will span six months, providing sufficient time to equip clinics to use CGM. The intervention includes development of clinic workflows for CGM prescribing and onboarding, provider education on CGM use and interpretation, training of clinic staff to support CGM initiation, and regular performance feedback on CGM prescribing rates.",[13],"Other: Enhanced CGM Interventions",{"label":15,"type":16,"description":17,"interventionNames":18},"Pre-implementation phase","ACTIVE_COMPARATOR","Patients in pre-implementation practices will receive the usual care under the direction of their primary care provider and practice.",[19],"Other: Standard of Care",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Enhanced CGM Interventions","The study intervention involves creating a streamlined workflow for CGM prescribing that does not restrict the treatment options available to patients or clinicians. SPARK-CGM implementation strategy includes three core practice transformations: (1) building clinic infrastructure by establishing CGM prescription workflows, and by training clinic staff to place CGM devices at the point of care, (2) provider training on accessing and using CGM data effectively in practice, and (3) regular feedback on prescription rates across the network.",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Standard of Care","Usual care",[15],[31],{"name":32,"affiliation":5,"role":33},"Jovan Milosavljevic, MD","PRINCIPAL_INVESTIGATOR",[35],{"name":36,"role":37,"phone":38,"phoneExt":25,"email":39},"Rosina Antwi","CONTACT","646-515-8399","rosina.antwi@einsteinmed.edu",[41],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":25},"Montefiore Medical Group (MMG)","RECRUITING","The Bronx","New York","10467","United States","US",{"type":50,"coordinates":51},"Point",[52,53],-73.86641,40.84985,{"lat":53,"lon":52},{"type":56,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[58],{"name":59,"class":6},"American Diabetes Association","100635106",false,"NCT07548372","SPARK-CGM Implementation","Supporting Primary Care Adoption, Resources, and Knowledge for Continuous Glucose Monitoring","Inclusion Criteria:\n\nClinic level:\n\n* All adult Montefiore primary care sites\n* Clinician and clinic staff will be eligible if they provide direct patient care or are involved in CGM prescribing, authorization, onboarding, or education at participating primary care clinics. Eligible clinicians include physicians, nurse practitioners, physician assistants, and clinicians in training. Eligible clinic staff may include nurses, medical assistants, and other relevant administrative staff\n\nPatient level:\n\n* Age 18 years or older\n* Receive primary care at participating sites\n* Diagnosis of any diabetes mellitus\n* Treated with insulin therapy\n\nExclusion Criteria:\n\nClinic level:\n\n\\- Sites participating in pilot phase of CGM initiative\n\nPatient level:\n\n\\- Existing CGM prescription within 24 months before the study start","ALL","18 Years",{"count":69,"type":70},20000,"ESTIMATED","INTERVENTIONAL",[73],"NA","Continuous glucose monitoring (CGM) is a technology that helps individuals with diabetes track their sugar levels in real-time, leading to more in-range blood sugars, fewer episodes of dangerously low blood sugar, and improved quality of life. Despite these benefits, CGM is not widely used in primary care settings, where most people receive their diabetes care. The investigators aim to make CGM more accessible and equitably prescribed in primary care practices. The study team will support primary care to increase CGM use with a program called SPARK-CGM (Supporting Primary Care Adoption, Resources, and Knowledge for CGM) across a large network of primary care clinics at Montefiore Medical Center. This program will provide primary care providers (PCPs) with education, tools, and support to incorporate CGM into their routine care for people with diabetes. Investigators plan to test SPARK-CGM to evaluate whether it increases CGM prescriptions who are eligible to receive this technology.",[76],"Diabetes Mellitus",[78,79,80,81],"Implementation","HbA1c","Multi-component Implementation","Continuous glucose monitoring","2026-06-22",{"date":84,"type":85},"2026-06-23","ACTUAL",{"date":87,"type":85},"2026-05-01",{"date":89,"type":70},"2028-05",{"name":5,"class":6},1]